Intraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL

Size: px
Start display at page:

Download "Intraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL"

Transcription

1 Intraoperative haemorrhage and haemostasis Dr. med. Christian Quadri Capoclinica Anestesia, ORL

2 Haemostasis is like love. Everybody talks about it, nobody understands it. JH Levy 2000 Intraoperative Haemorrhage and Haemostasis Pag. 2

3 Disclosure - No conflict of interests Intraoperative Haemorrhage and Haemostasis Pag. 3

4 Intraoperative Haemorrhage and Haemostasis Pag. 4

5 Contents 1. Introduction 2. Pro-coagulants use in case of haemorrhage 3. Take home messages Intraoperative Haemorrhage and Haemostasis Pag. 5

6 Introduction - Does the problem exist? Intraoperative Haemorrhage and Haemostasis Pag. 6

7 Introduction Bleeding: ü Leading cause of preventable death in trauma Cothren CC et al. World J Surg 2007; 31: ü Leading cause of maternal mortality in resource-poor countries and severe morbidity in resource-rich countries Collis RE, Collins PW. Anaesthesia 2015; 70 (Suppl. 1): ü Blood transfusions associated with several adverse patient outcomes Withlock LW et al. BMJ 2015; 2015;350:h3037 Intraoperative Haemorrhage and Haemostasis Pag. 7

8 Introduction Anesth Analg 2017 Oct 19; Epub ahead of print Detection and treatment of preoperative anaemia Optimize haemostasis -> minimize blood loss Harnessing + optimizing patient physiological reserve of anaemia (incl. transf. trigger) Intraoperative Haemorrhage and Haemostasis Pag. 8

9 Introduction Anesth Analg 2017 Oct 19; Epub ahead of print Detection and treatment of preoperative anaemia Optimize haemostasis -> minimize blood loss Harnessing + optimizing patient physiological reserve of anaemia (incl. transf. trigger) Intraoperative Haemorrhage and Haemostasis Pag. 9

10 Introduction Anesth Analg 2017 Oct 19; Epub ahead of print Detection and treatment of preoperative anaemia Harnessing + optimizing patient physiological reserve of anaemia (incl. transf. trigger) Optimize haemostasis -> minimize blood loss Intraoperative Haemorrhage and Haemostasis Pag. 10

11 Introduction Detection and treatment of preoperative anaemia Optimize haemostasis -> minimize blood loss Harnessing + optimizing patient physiological reserve of anaemia (incl. transfusion trigger) Intraoperative Haemorrhage and Haemostasis Pag. 11

12 Introduction Mezar T et al. JAMA Surg 2017; 152 (6): Intraoperative Haemorrhage and Haemostasis Pag. 12

13 Introduction Beds for acute treatment: : 1996 U of RBCs, 460 U FFP, 140 Tc concentrates MT s? Distribuzione letti nel canton Ticino ( ), DSS Trasfusione CRS Svizzera Italiana Intraoperative Haemorrhage and Haemostasis Pag. 13

14 Introduction Injury, Int. J. Care Injured 2017; 48: 5-12 Haemorrhage Haemorrhage Intraoperative Haemorrhage and Haemostasis Pag. 14

15 Intraoperative Haemorrhage and Haemostasis Pag. 15

16 Introduction - Haemostatic resuscitation based on tests and coagulation factor concentrates driven? Innerhofer P. Lancet Haematol. 2017; 4: Intraoperative Haemorrhage and Haemostasis Pag. 16

17 Introduction - Empiric administration of blood products in predefined and fixed ratio? : : PRBC FFP Platelets Holcomb JB. Jama Surg. 2013; 148: Intraoperative Haemorrhage and Haemostasis Pag. 17

18 Introduction ROTEM Intraoperative Haemorrhage and Haemostasis Pag. 18

19 Introduction Intraoperative Haemorrhage and Haemostasis Pag. 19

20 Viscoelastic Testing ROTEM Rotem.de From Winearels J et al. Injury; 2017; 48: Intraoperative Haemorrhage and Haemostasis Pag. 20

21 Viscoelastic Testing From Schöchl H et al. Critical Care. 2010; 14(2):R55 Intraoperative Haemorrhage and Haemostasis Pag. 21

22 Intraoperative Haemorrhage and Haemostasis Pag. 22 Levy JH Anesthesiology. 2018; 128:

23 Tranexamic Acid Lancet; 2010; 376:23-32 Ø Mortality was reduced with tranexamic acid (14.5 vs. 16.0%; P = ) - Over 20,000 bleeding trauma: v tranexamic acid or matching placebo Ø Only 5% of patients died because of bleeding Ø Only 50% of patients received blood transfusions - Tranexamic acid 1g + 1g over 8 hours Ø No difference in the amount of blood transfused between groups à Mechanism of action? Intraoperative Haemorrhage and Haemostasis Pag. 23

24 Fibrinolysis J Thromb Haemost 2013; 11: Prospective cohort study of 303 trauma patients - Fibrinolytic activation: plasmin antiplasmin (PAP) complex, Thromboelastometry (TEM) Intraoperative Haemorrhage and Haemostasis Pag. 24

25 Fibrinolysis J Thromb Haemost 2013; 11: Ø Fibrinolytic activation is associated with the degree of shock and the injury severity Intraoperative Haemorrhage and Haemostasis Pag. 25

26 Fibrinolysis J Thromb Haemost 2013; 11: % of patients % mortality Intraoperative Haemorrhage and Haemostasis Pag. 26

27 Fibrinolysis J Trauma Acute Care Surg. 2014; 77(6): Intraoperative Haemorrhage and Haemostasis Pag. 27

28 Tranexamic Acid - Tranexamic acid: 1g as soon as possible to the trauma patient who is bleeding or at risk of significant hemorrhage (+1 g over 8 h). (Grade 1A) - Tranexamic acid: within 3 h after injury. (Grade 1B) Rossaint R et al. et al. Critical Care :100 Intraoperative Haemorrhage and Haemostasis Pag. 28

29 Tranexamic Acid J Surg Res 2013; 184: Ø 1114 patients enrolled in RTs Ø TXA significantly reduce perioperative blood loss and blood transfusion following unilateral TKA Ø No increased risk of venous thromboembolisms or other adverse events Intraoperative Haemorrhage and Haemostasis Pag. 29

30 Tranexamic Acid Ø Death due to bleeding and laparotomy to control bleeding significantly reduced Ø Within 3 hours of giving birth Ø No increased risk of thromboembolic events Intraoperative Haemorrhage and Haemostasis Pag. 30

31 Fibrinogen Anesth Analg 2012; 114: From John W. Weisel, PhD, University of Pennsylvania Intraoperative Haemorrhage and Haemostasis Pag. 31

32 Fibrinogen Anesth Analg 1995; 81: Intraoperative Haemorrhage and Haemostasis Pag. 32

33 Fibrinogen J Thromb Haemost 2012; 10: Ø Fibrinogen depletion associated with poor outcome 2.4 g/l Ø Fibrinogen level do not normalize with high dose of FFP Low Fibrinogen by patients with acute trauma coagulopathy 1.6 g/l Ø Correction of the coagulopathy ex vivo with fibrinogen concentrate Intraoperative Haemorrhage and Haemostasis Pag. 33

34 Fibrinogen J Thromb Haemost 2007; 5: Intraoperative Haemorrhage and Haemostasis Pag. 34

35 Fibrinogen British Journal of Anaesthesia; 2015: 114 (4): Ø 2g Fibrinogen vs placebo in patient with severe PPH Ø Primary outcome: RBC transfusion up to 6 weeks postpartum Intraoperative Haemorrhage and Haemostasis Pag. 35

36 Fibrinogen Intraoperative Haemorrhage and Haemostasis Pag. 36 British Journal of Anaesthesia; 2015: 114 (4):

37 Fibrinogen Conclusion: Ø No benefit of pre-emptive fibrinogen for severe PPH, if plasma level is normal Intraoperative Haemorrhage and Haemostasis Pag. 37 British Journal of Anaesthesia; 2015: 114 (4):

38 Fibrinogen Most relevant population may not have been included Intraoperative Haemorrhage and Haemostasis Pag. 38 British Journal of Anaesthesia; 2015: 114 (4):

39 Fibrinogen Kozek-Langenecker SA et al. Eur J Anaesthesiol. 2017; 34(6): Fibrinogen concentration of less than 1.5 to 2g/l is considered as hypofibrinogenaemia in acquired coagulopathy and is associated with increased bleeding risk. C - We recommend treatment of hypofibrinogenaemia in bleeding patients. 1C Intraoperative Haemorrhage and Haemostasis Pag. 39

40 Factor XIII Responsible for fibrin crosslinking Antifibrinolytic properties by crosslinking α2-plasmin inhibitor to fibrin From Levy et al. Transfusion. 2013;53: Intraoperative Haemorrhage and Haemostasis Pag. 40

41 Factor XIII Transfus Med Hemother. 2017; 44: patients - In patients with lowest clot firmness v FXIII most important independent modulator Intraoperative Haemorrhage and Haemostasis Pag. 41

42 Factor XIII Transfus Med Hemother. 2017; 44:85 92 FXIII activity Intraoperative Haemorrhage and Haemostasis Pag. 42

43 Factor XIII Stroke 2002; 33(66): Intraoperative Haemorrhage and Haemostasis Pag. 43

44 Factor XIII Haemophilia 2014; 20: Intraoperative Haemorrhage and Haemostasis Pag. 44

45 Platelets J Trauma Acute Care Surg. 2012; 73 (1): critically-injured trauma patients - Platelets hypofunction: v 45 % of the patients at admission v 91 % during the stay in the ICU Intraoperative Haemorrhage and Haemostasis Pag. 45

46 Platelets - Maintain platelet count > /l. (Grade 1C) - Maintain platelet count > /l in patients with ongoing bleeding and/or TBI. (Grade 2C) Rossaint R et al. et al. Critical Care :100 Intraoperative Haemorrhage and Haemostasis Pag. 46

47 Plasmatic haemostasis Intraoperative Haemorrhage and Haemostasis Pag. 47

48 Thrombin generation Intraoperative Haemorrhage and Haemostasis Pag. 48

49 Prothrombin complex concentrate Anesth Analg 2016; 122(5): PCC Intraoperative Haemorrhage and Haemostasis Pag. 49

50 Prothrombin complex concentrate Anesth Analg 2016; 122(5): Correct hypofibrinogenemia and thrombocytopenia first - High thromboembolic postoperative risk Intraoperative Haemorrhage and Haemostasis Pag. 50

51 Prothrombin complex concentrate J Trauma Acute Care Surg. 2015; 78 (6): Intraoperative Haemorrhage and Haemostasis Pag. 51

52 Fresh Frozen Plasma Br J Haematol 2004;125 (1): Only 30 ml/kg FFP adequately corrected all individual coagulation factors Intraoperative Haemorrhage and Haemostasis Pag. 52

53 Fresh Frozen Plasma J Am Coll Surg 2010; 210 (6): Ø Associated with substantial increase in complications, in particular ARDS Ø No improvement in survival Intraoperative Haemorrhage and Haemostasis Pag. 53

54 Fresh Frozen Plasma Anesth Analg 2011; 112 (6): Intraoperative Haemorrhage and Haemostasis Pag. 54

55 Take home message Be prepared! Intraoperative Haemorrhage and Haemostasis Pag. 55

56 TXA: take home message - Trauma: < 3 h v fibrinolysis activation à increased mortality v waiting for results about fibrinolysis shutdown - Orthopedic surgery: - Obstetric: in case of PPH < 3 h - Cardiac surgery (CPB): Intraoperative Haemorrhage and Haemostasis Pag. 56

57 Fibrinogen: take home message - Key for haemostatic function. First haemostatic factor to reach critical level, especially in trauma - Treat hypofibrinogenaemia (Fibrinogen concentrate), target g/l - PPH: Fibrinogen < 2 g/l à marker for severe haemorrhage - Pre-emptive administration only in selected cases? Intraoperative Haemorrhage and Haemostasis Pag. 57

58 Factor XIII: take home message - Consider measurement in severe bleeding - Consider administration in activity < 60% - Critical level are probably rapidly reached in severe PPH - Strong evidence is still lacking Intraoperative Haemorrhage and Haemostasis Pag. 58

59 Platelets: take home message - In critically-injured platelets dysfunction may be present despite normal counts - Target: 50 x 10 9 /l. 100 x 10 9 /l in patients with ongoing bleeding and/or TBI Intraoperative Haemorrhage and Haemostasis Pag. 59

60 Prothrombin complex concentrate: Take home message - Off label use in non Vitamin K antagonist related bleeding - Successfully used in Trauma Induced Coagulopathy - Administration should be based on (viscoelastic) measurements, after correction of hypofibrinogenaemia and thrombocytopenia - Thromboembolic risks. Low dosage: I.U. Intraoperative Haemorrhage and Haemostasis Pag. 60

61 Fresh Frozen Plasma: take home message - Limited effect to correct coagulation disturbances - More complications if administered to patients not requiring massive transfusion - Potential protective effect on endothelial Glycocalyx Intraoperative Haemorrhage and Haemostasis Pag. 61

62 Intraoperative Haemorrhage and Haemostasis Pag. 62

How can ROTEM testing help you in trauma?

How can ROTEM testing help you in trauma? How can ROTEM testing help you in trauma? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential diagnosis

More information

How can ROTEM testing help you in cardiac surgery?

How can ROTEM testing help you in cardiac surgery? How can ROTEM testing help you in cardiac surgery? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential

More information

2012, Görlinger Klaus

2012, Görlinger Klaus Gerinnungsmanagement der Gegenwart - wie gehen wir heute vor? 25. Allander Gerinnungsrunde am 15. März 2012 Klaus Görlinger Universitätsklinikum Essen klaus@goerlinger.net CSL Behring GmbH Octapharma AG

More information

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):

More information

Coagulopathy: Measuring and Management. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine

Coagulopathy: Measuring and Management. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine Coagulopathy: Measuring and Management Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine No Financial Disclosures Objectives Define coagulopathy of trauma Define

More information

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference John A. Aucar, MD, MSHI, FACS, CPE EmCare Acute Care Surgery Del Sol Medical Center Associate Professor, University

More information

Transfusion Requirements and Management in Trauma RACHEL JACK

Transfusion Requirements and Management in Trauma RACHEL JACK Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension

More information

Massive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad

Massive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad Massive transfusion: Recent advances, guidelines & strategies Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad Massive Hemorrhage Introduction Hemorrhage is a major cause

More information

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial

More information

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD Massive Transfusion MPQC Spring Summit April 29, 2015 Roger Belizaire MD PhD Take home points 1. Blood is always available. Requests for massive transfusion or emergency release typically only require

More information

Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out?

Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out? Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out? Jessica K. Reynolds, MD Assistant Professor of Surgery University of Kentucky, Department of Trauma

More information

Recombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD

Recombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD Recombinant Activated Factor VII: Useful Department of Surgery Grand Rounds 11/8/10 David Mauchley MD Hemostasis and Coagulation Traditional cascade model Two convergent pathways Series of proteolytic

More information

Transfusion in major bleeding: new insights. Gert Poortmans

Transfusion in major bleeding: new insights. Gert Poortmans Transfusion in major bleeding: new insights Gert Poortmans Trauma Cardiac Surgery Major Surgery with ongoing blood loss Burn Surgery Lethal Triad Polytransfusion: definitions Coagulation Coagulopathy of

More information

Shock and Resuscitation: Part II. Patrick M Reilly MD FACS Professor of Surgery

Shock and Resuscitation: Part II. Patrick M Reilly MD FACS Professor of Surgery Shock and Resuscitation: Part II Patrick M Reilly MD FACS Professor of Surgery Trauma Patient 1823 / 18 Police Dropoff Torso GSW Lower Midline / Right Buttock Shock This Monday Trauma Patient 1823 / 18

More information

Mechanisms of Trauma Coagulopathy. Dr B M Schyma Changi General Hospital Singapore

Mechanisms of Trauma Coagulopathy. Dr B M Schyma Changi General Hospital Singapore Mechanisms of Trauma Coagulopathy Dr B M Schyma Changi General Hospital Singapore HAEMORRHAGE A continued cause of PREVENTABLE death. 24% of trauma patients are coagulopathic on arrival 1 56% of severe

More information

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Transfusion & Mortality. Philippe Van der Linden MD, PhD Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:

More information

Coagulation, Haemostasis and interpretation of Coagulation tests

Coagulation, Haemostasis and interpretation of Coagulation tests Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect

More information

Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015

Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015 Management of the Trauma Patient Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015 Saturday Night 25 yo M s/p high speed MVC Hypotensive in the ED, altered

More information

Management of Massive Transfusion. Philippe Van der Linden MD, PhD CHU Brugmann-HUDERF, Free University of Brussels

Management of Massive Transfusion. Philippe Van der Linden MD, PhD CHU Brugmann-HUDERF, Free University of Brussels Management of Massive Transfusion Philippe Van der Linden MD, PhD CHU Brugmann-HUDERF, Free University of Brussels Massive Hemorrhage: definition? Replacement of one blood mass in less than 24 hours Dynamic

More information

DIAGNOSTIC TESTING IN PATIENT BLOOD MANAGEMENT PROGRAMS

DIAGNOSTIC TESTING IN PATIENT BLOOD MANAGEMENT PROGRAMS DIAGNOSTIC TESTING IN PATIENT BLOOD MANAGEMENT PROGRAMS The Role of Diagnostic Point-of-Care Testing Diagnostic testing is an essential component of Patient Blood Management. The accurate assessment of

More information

PBM: The Future of Transfusion December 6 th 2012 East of England RTC. Sue Mallett Royal Free London NHS Foundation Trust

PBM: The Future of Transfusion December 6 th 2012 East of England RTC. Sue Mallett Royal Free London NHS Foundation Trust PBM: The Future of Transfusion December 6 th 2012 East of England RTC Sue Mallett Royal Free London NHS Foundation Trust Patient Blood Management The 3 Pillars Pre-operative optimization of anaemia Minimizing

More information

1 Transfusion Medicine and Blood Bank Department, H. São João, Centro

1 Transfusion Medicine and Blood Bank Department, H. São João, Centro Original Article Interventional Algorithms for the Control of Coagulopathic Bleeding in Surgical, Trauma, and Postpartum Settings: Recommendations From the Share Network Group Clinical and Applied Thrombosis/Hemostasis

More information

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard The principle of 1:1:1 blood product use in the resuscitation of trauma victims K. D. Boffard Milpark Hospital Department of Surgery University of the Witwatersrand Johannesburg, South Africa Annual Controversies

More information

Resuscitation Update

Resuscitation Update Resuscitation Update? Dr. Edward Pyun Jr., M.D. FACS Trauma Medical Director/Surgical ICU Director OSF St. Anthony Medical Center Trauma Services Perryville Surgical Associates November 10, 2012 2009 Recommendations

More information

Pathophysiologie und Therapie bei Massenblutung

Pathophysiologie und Therapie bei Massenblutung Swisstransfusion Bern, 7. September 2012 Pathophysiologie und Therapie bei Massenblutung Lorenzo ALBERIO Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor Coagulopathy of Trauma Haemorrhage

More information

Hydroxyethyl starch and bleeding

Hydroxyethyl starch and bleeding Hydroxyethyl starch and bleeding Anders Perner Dept. of Intensive Care, Rigshospitalet University of Copenhagen Scandinavian Critical Care Trials Group Intensive Care Medicine COIs Ferring, LFB - Honoraria

More information

Clinical Overview of Coagulation Testing Issues

Clinical Overview of Coagulation Testing Issues Clinical Overview of Coagulation Testing Issues Adam M. Vogel, MD Assistant Professor, Division of Pediatric Surgery Washington University in St. Louis School of Medicine September 19, 2014 Disclosure

More information

Dubbi e certezze nella gestione delle emorragie con metodiche point-of-care

Dubbi e certezze nella gestione delle emorragie con metodiche point-of-care Sessione Educazionale 4 : Gestione del paziente emorragico Dubbi e certezze nella gestione delle emorragie con metodiche point-of-care P. Simioni Università di Padova hemostasis Vascular phase Platelet

More information

Unrestricted. Dr ppooransari fellowship of perenatalogy

Unrestricted. Dr ppooransari fellowship of perenatalogy Unrestricted Dr ppooransari fellowship of perenatalogy Assessment of severity of hemorrhage Significant drops in blood pressure are generally not manifested until substantial bleeding has occurred, and

More information

Groupe d Intérêt en Hémostase Périopératoire

Groupe d Intérêt en Hémostase Périopératoire How do I treat massive bleeding? Red blood cell / plasma / platelet ratio and massive transfusion protocols Anne GODIER Service d Anesthésie-Réanimation Hopital Cochin Paris Groupe d Intérêt en Hémostase

More information

Hemostatic Resuscitation

Hemostatic Resuscitation Hemostatic Resuscitation 30 th David Miller Trauma Symposium Bill Beck, MD Assistant Professor of Surgery Trauma, Emergency General Surgery, Critical Care Disclosures None Again. Mac user. Why I Like Trauma?

More information

Balanced Transfusion Resuscitation

Balanced Transfusion Resuscitation Transparency in Transfusion Medicine 2013 Balanced Transfusion Resuscitation HGD Hendriks MD, PhD University Medical Center Groningen Balancing 1 2 3 Preoperative Peroperative Postoperative Balanced Coagulation

More information

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE CONTENTS Definition Indications Transfusion trigger Massive transfusion protocol Complications DEFINITION Massive transfusion:

More information

Treatment of postpartum haemorrhage: NATA consensus statement

Treatment of postpartum haemorrhage: NATA consensus statement Treatment of postpartum haemorrhage: NATA consensus statement Jakob Stensballe MD, PhD, Consultant Anaesthetist & Transfusion Specialist Chair of Scientific Committee, NATA Section for Transfusion Medicine,

More information

2 Liters. Goal: Basic Algorithm Volume Resuscitation in Trauma. Initial Fluids. Blood. Where do Blood Products Come From?

2 Liters. Goal: Basic Algorithm Volume Resuscitation in Trauma. Initial Fluids. Blood. Where do Blood Products Come From? Goal: Basic Algorithm Volume Resuscitation in Trauma Sanjay Arora MD Associate Professor of Emergency Medicine Keck School of Medicine at USC Los Angeles County + USC Medical Center May 23, 2012 Initial

More information

Financial Disclosure. Objectives 9/24/2018

Financial Disclosure. Objectives 9/24/2018 Hemorrhage and Transfusion Adjuncts in the Setting of Damage Control Joseph Cuschieri, MD FACS Professor of Surgery, University of Washington Adjunct Professor of Orthopedics and Neurosurgery, University

More information

Prothrombin Complex Concentrate- Octaplex. Octaplex

Prothrombin Complex Concentrate- Octaplex. Octaplex Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation

More information

Managing Coagulopathy in Intensive Care Setting

Managing Coagulopathy in Intensive Care Setting Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary

More information

My Bloody Talk. Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne

My Bloody Talk. Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne My Bloody Talk Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne Disclosures No conflicts of interest Interest in conflict Blood transfusion Massive transfusion definitions Transfusion

More information

3/16/15. Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation. Obligatory Traumatologist Slide

3/16/15. Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation. Obligatory Traumatologist Slide Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation Courtney Sommer, MD MPH Duke Trauma Symposium March 12, 2015 Obligatory Traumatologist Slide In 2010 trauma was leading

More information

Management of Challenging Bleeding: Patients with Coagulopathy

Management of Challenging Bleeding: Patients with Coagulopathy Management of Challenging Bleeding: Patients with Coagulopathy Joanne E Joseph Department of Haematology, SydPath St Vincent s Hospital University of NSW Sydney First and foremost.. It helps to know which

More information

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.

More information

A Guide To Safe Blood Transfusion Practice

A Guide To Safe Blood Transfusion Practice A Guide To Safe Blood Transfusion Practice Marie Browett, Pavlina Sharp, Fiona Waller, Hafiz Qureshi, Malcolm Chambers (on behalf of the UHL Blood Transfusion Team) A Guide To Safe Blood Transfusion Practice

More information

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation

More information

WELCOME. Evaluation Summary

WELCOME. Evaluation Summary WELCOME Evaluation Summary 489 delegates from 40 countries Delegate s specialty 239 respondents Delegate s professional activity 208 respondents Overall Evaluation This symposium was helpful for your clinical

More information

TRANSFUSIONS FIRST, DO NO HARM

TRANSFUSIONS FIRST, DO NO HARM TRANSFUSIONS FIRST, DO NO HARM BECAUSE BLOOD CAN KILL 7 TRALI DEATHS SINCE 2002 WMC 5 women BECAUSE In OB you are transfusing 2 instead of 1 BECAUSE BLOOD IS A LIQUID TRANSPLANT RISKS versus BENEFITS versus

More information

Approach to disseminated intravascular coagulation

Approach to disseminated intravascular coagulation Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS

More information

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting

More information

Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery

Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Butler Journal of Undergraduate Research Volume 2 Article 24 2016 Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Lisa K. LeCleir Butler University, lisa.lecleir@gmail.com

More information

Kay Barrera MD. Surgery Grand Rounds June 19, 2014 SUNY Downstate

Kay Barrera MD. Surgery Grand Rounds June 19, 2014 SUNY Downstate Kay Barrera MD Surgery Grand Rounds June 19, 2014 SUNY Downstate Kay Barrera MD Surgery Grand Rounds June 19, 2014 SUNY Downstate Outline Why are we talking about this SCORE expectations When do we use

More information

When Should I Use Tranexamic Acid for Children? Dr Andrea Kelleher Consultant Adult and Paediatric Cardiac Anaesthetist

When Should I Use Tranexamic Acid for Children? Dr Andrea Kelleher Consultant Adult and Paediatric Cardiac Anaesthetist When Should I Use Tranexamic Acid for Children? Dr Andrea Kelleher Consultant Adult and Paediatric Cardiac Anaesthetist When? When a drug is licenced for (the proposed) use When its use is supported by

More information

Platelet function in cardiovascular surgery. ROTEM User Meeting, UZ Leuven, 9 November Klaus Görlinger, MD Munich, Germany

Platelet function in cardiovascular surgery. ROTEM User Meeting, UZ Leuven, 9 November Klaus Görlinger, MD Munich, Germany Platelet function in cardiovascular surgery ROTEM User Meeting, UZ Leuven, 9 November 2015 Klaus Görlinger, MD Munich, Germany Disclosures Senior Consultant for Anesthesiology, Emergency and Intensive

More information

EMSS17: Bleeding patients course material

EMSS17: Bleeding patients course material EMSS17: Bleeding patients course material Introduction During the bleeding patients workshop at the Emergency Medicine Summer School 2017 (EMSS17) you will learn how to assess and treat bleeding patients

More information

VanderbiltEM.com. Prehospital STEMIs. EMS Today 2018 Research That Should Be On Your Radar Screen 3/1/2018

VanderbiltEM.com. Prehospital STEMIs. EMS Today 2018 Research That Should Be On Your Radar Screen 3/1/2018 EMS Today 2018 Research That Should Be On Your Radar Screen Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN VanderbiltEM.com

More information

Hemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands

Hemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Hemostasis and thrombosis in patients with liver disease Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Importance of the liver in hemostasis Synthesis of Coagulation factors Fibrinolytic proteins

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage

Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage Intensive Care Med (2015) 41:239 247 DOI 10.1007/s00134-014-3584-1 ORIGINAL Sirat Khan Ross Davenport Imran Raza Simon Glasgow Henry D. De Ath Pär I. Johansson Nicola Curry Simon Stanworth Christine Gaarder

More information

Diagnostics Assessment Report (DAR) - Comments

Diagnostics Assessment Report (DAR) - Comments Diagnostics Assessment Report (DAR) - s TEM International 1. General comments and limitations of the study: This manuscript clearly demonstrates the advantages of VETs compared to SLTs. However, an important

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

The Bleeding Jehovah s Witness: A Nightmare Scenario?

The Bleeding Jehovah s Witness: A Nightmare Scenario? The Bleeding Jehovah s Witness: A Nightmare Scenario? David Smith, Bristol Hospital Liaison Committee for Jehovah s Witnesses SW RTC: Bleeding in the Medical Patient - 21 February 2018 Jehovah s Witnesses

More information

Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document"

Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the Seville Document R Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document" Santiago R. Leal-Noval 1, Manuel Muñoz 2, Marisol Asuero 3, Enric Contreras 3, José

More information

Hemostatic Resuscitation in Trauma. Joanna Davidson, MD 6/6/2012

Hemostatic Resuscitation in Trauma. Joanna Davidson, MD 6/6/2012 Hemostatic Resuscitation in Trauma { Joanna Davidson, MD 6/6/2012 Case of HM 28 yo M arrives CCH trauma bay 5/27/12 at 241 AM Restrained driver in low speed MVC after getting shot in the chest Arrived

More information

TXA. Things Change. Tranexamic Acid TXA. Resuscitation 2017 TXA In The ED March 31, MAST Trousers. High Flow IV Fluids.

TXA. Things Change. Tranexamic Acid TXA. Resuscitation 2017 TXA In The ED March 31, MAST Trousers. High Flow IV Fluids. Resuscitation 2017 In The ED March 31, 2017 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN SECURE THE ABC S MAST

More information

Major Haemorrhage Protocol. Commentary

Major Haemorrhage Protocol. Commentary Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey

More information

ADVANCES IN HEMATOLOGY

ADVANCES IN HEMATOLOGY ADVANCES IN HEMATOLOGY Current Developments in the Management of Hematologic Disorders Section Editor: Craig M. Kessler, MD Antifibrinolytic Agents in Acquired Bleeding Disorders Mark Walsh, MD Emergency

More information

Citation for published version (APA): Müller, M. C. A. (2014). Coagulopathy and plasma transfusion in critically ill patients

Citation for published version (APA): Müller, M. C. A. (2014). Coagulopathy and plasma transfusion in critically ill patients UvA-DARE (Digital Academic Repository) Coagulopathy and plasma transfusion in critically ill patients Müller, Marcella Link to publication Citation for published version (APA): Müller, M. C. A. (2014).

More information

Code Blue Caesarean at midnight!

Code Blue Caesarean at midnight! Code Blue Caesarean at midnight! Disclaimer / Pre-amble These cases have been de-identified to protect the identity of the patient and the treating teams. These are all real cases and real ROTEMs. The

More information

Hemostatic derangement in Dengue infection

Hemostatic derangement in Dengue infection Hemostatic derangement in Dengue infection By Assoc. Prof. Darintr Sosothikul, MD Pediatric Hematology-Oncology division, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University

More information

Pediatric massive transfusion protocols

Pediatric massive transfusion protocols University of New Mexico UNM Digital Repository Emergency Medicine Research and Scholarship Emergency Medicine 2014 Pediatric massive transfusion protocols Ramsey Tate Follow this and additional works

More information

Precilla V. Veigas 1, Jeannie Callum 2, Sandro Rizoli 3, Bartolomeu Nascimento 4 and Luis Teodoro da Luz 4*

Precilla V. Veigas 1, Jeannie Callum 2, Sandro Rizoli 3, Bartolomeu Nascimento 4 and Luis Teodoro da Luz 4* Veigas et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine (2016) 24:114 DOI 10.1186/s13049-016-0308-2 REVIEW Open Access A systematic review on the rotational thrombelastometry

More information

Blood products and plasma substitutes

Blood products and plasma substitutes Blood products and plasma substitutes Plasma substitutes Dextran 70 and polygeline are macromolecular substances which are metabolized slowly; they may be used to expand and maintain blood volume in shock

More information

Perioperative coagulation management during cardiac surgery

Perioperative coagulation management during cardiac surgery REVIEW C URRENT OPINION Perioperative coagulation management during cardiac surgery Christian F. Weber, Matthias Klages, and Kai Zacharowski Purpose of review Cardiac surgery patients commonly present

More information

Blood Management and Protocol Use in Active Bleeding

Blood Management and Protocol Use in Active Bleeding Blood Management and Protocol Use in Active Bleeding John A. Norton, DO Assistant Professor Clinical Department of Anesthesiology The Ohio State University Wexner Medical Center Acknowledgements Stephanie

More information

Review Article Treatment of Acute Coagulopathy Associated with Trauma

Review Article Treatment of Acute Coagulopathy Associated with Trauma ISRN Critical Care Volume 2013, Article ID 783478, 7 pages http://dx.doi.org/10.5402/2013/783478 Review Article Treatment of Acute Coagulopathy Associated with Trauma Carolina Ruiz and Max Andresen Departamento

More information

5/30/2013. I have no conflicts of interest to disclose. Alicia Privette, MD Trauma & Critical Care Fellow. Trauma = #1 cause of death persons <40 yo 1

5/30/2013. I have no conflicts of interest to disclose. Alicia Privette, MD Trauma & Critical Care Fellow. Trauma = #1 cause of death persons <40 yo 1 I have no conflicts of interest to disclose. Alicia Privette, MD Trauma & Critical Care Fellow Trauma = #1 cause of death persons

More information

Damage Control Resuscitation

Damage Control Resuscitation Damage Control Resuscitation H M Cassimjee Critical Care Specialist Department of Critical Care & Level 1 Trauma Unit Inkosi Albert Luthuli Central Hospital Damage Control Resuscitation only for DAMAGED

More information

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation

More information

Management of trauma-induced coagulopathy (TIC): a synopsis of the updated European trauma guideline

Management of trauma-induced coagulopathy (TIC): a synopsis of the updated European trauma guideline Editorial Page 1 of 7 Management of trauma-induced coagulopathy (TIC): a synopsis of the updated European trauma guideline Marc Maegele 1,2 1 Department for Trauma and Orthopedic Surgery, Cologne-Merheim

More information

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary Increasing use of Novel Oral Anticoagulants (NOACs) in the management of prophylaxis and management of venous thromboembolism and in

More information

When should I transfuse platelets and plasma for children? Dr Liz Chalmers. Consultant Paediatric Haematologist Royal Hospital for Children Glasgow

When should I transfuse platelets and plasma for children? Dr Liz Chalmers. Consultant Paediatric Haematologist Royal Hospital for Children Glasgow When should I transfuse platelets and plasma for children? Dr Liz Chalmers Consultant Paediatric Haematologist Royal Hospital for Children Glasgow When should I transfuse platelets and plasma in children?

More information

Bleeding and Management of Coagulopathy

Bleeding and Management of Coagulopathy Bleeding and Management of Coagulopathy Jerrold H. Levy, MD, FAHA Professor of Anesthesiology Deputy Chair for Research Emory University School of Medicine Director, Cardiothoracic Anesthesiology CT Anesthesiology

More information

Heme (Bleeding and Coagulopathies) in the ICU

Heme (Bleeding and Coagulopathies) in the ICU Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related

More information

PEDIATRIC MASSIVE TRANSFUSION

PEDIATRIC MASSIVE TRANSFUSION PEDIATRIC MASSIVE TRANSFUSION CHELSEA RUNKLE RN, BSN, CCRN, SRNA CROZER-CHESTER MEDICAL CENTER/VILLANOVA UNIVERSITY NURSE ANESTHESIA PROGRAM LEADING CAUSE OF DEATH Trauma Motor vehicle accidents, nonaccidental

More information

Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: a retrospective study

Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: a retrospective study Yin et al. World Journal of Emergency Surgery 2014, 9:28 WORLD JOURNAL OF EMERGENCY SURGERY RESEARCH ARTICLE Open Access Goal-directed transfusion protocol via thrombelastography in patients with abdominal

More information

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore MANAGEMENT OF COMMON BLEEDING DISORDERS Auro Viswabandya Department of Haematology, CMC, Vellore BLOOD CLOT : PRIMARY HAEMOSTASIS (Platelets) + SECONDARY HAEMOSTASIS (Coagulation Factors) HAEMOSTATIC DISORDERS

More information

Factors affecting postoperative blood loss in children undergoing cardiac surgery

Factors affecting postoperative blood loss in children undergoing cardiac surgery Faraoni and Van der Linden Journal of Cardiothoracic Surgery 2014, 9:32 LETTER TO THE EDITOR Factors affecting postoperative blood loss in children undergoing cardiac surgery David Faraoni * and Philippe

More information

EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION

EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Overview of massive transfusion practice

Overview of massive transfusion practice ORIGINAL RESEARCH Overview of massive transfusion practice Irena Seferi 1, Erind Cafi 1 1 National Blood Transfusion Centre (NBTC), Tirana, Albania. Corresponding Author: Irena Seferi, MD, PhD; Address:

More information

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant. Lab Matters study day Oake Manor, Taunton, 8 th July 2015

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant. Lab Matters study day Oake Manor, Taunton, 8 th July 2015 Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant Lab Matters study day Oake Manor, Taunton, 8 th July 2015 NPSA Rapid Response Report 2010 Transfusion of blood and blood components

More information

HEMOSTASIS AND LIVER DISEASE. P.M. Mannucci. Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy

HEMOSTASIS AND LIVER DISEASE. P.M. Mannucci. Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy HEMOSTASIS AND LIVER DISEASE P.M. Mannucci Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy 1964 ACQUIRED HEMOSTASIS DISORDERS: LIVER DISEASE Severe liver disease not uncommonly

More information

Patient blood management and perioperative anaemia

Patient blood management and perioperative anaemia BJA Education, 17 (1): 28 34 (2017) doi: 10.1093/bjaed/mkw061 Matrix referenece 1I05, 2A05, 3I00 Patient blood management and perioperative anaemia S V Thakrar MBBS BSc(Hons) MRCP FRCA 1, *, B Clevenger

More information

The current place of tranexamic acid in the management of bleeding

The current place of tranexamic acid in the management of bleeding Anaesthesia 2015, 70 (Suppl. 1), 50 53 Review Article doi:10.1111/anae.12910 The current place of tranexamic acid in the management of B. J. Hunt 1,2 1 Professor of Thrombosis & Haemostasis, Kings College

More information

Acute traumatic coagulopathy: pathophysiology and resuscitation

Acute traumatic coagulopathy: pathophysiology and resuscitation British Journal of Anaesthesia, 117 (S3): iii31 iii43 (2016) doi: 10.1093/bja/aew328 Review Article Acute traumatic coagulopathy: pathophysiology and resuscitation J. W. Simmons* and M. F. Powell The University

More information

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN PROTHROMBIN COMPLEX PRODUCTS (CPMP/BPWG/3735/02)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN PROTHROMBIN COMPLEX PRODUCTS (CPMP/BPWG/3735/02) European Medicines Agency Human Medicines Evaluation Unit London, 21 October 2004 Corrigendum, 18 November 2004 CPMP/BPWG/3735/02 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN

More information

Hypotensive Resuscitation

Hypotensive Resuscitation Curr Anesthesiol Rep (2014) 4:209 215 DOI 10.1007/s40140-014-0064-7 ANESTHESIA FOR TRAUMA (J-F PITTET, SECTION EDITOR) Hypotensive Resuscitation Jeremy B. Smith Jean-Francois Pittet Albert Pierce Published

More information

CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin

CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin DISCLOSURES None Objective(s): Our department routinely used

More information

Major Haemorrhage Transfusion Pathway

Major Haemorrhage Transfusion Pathway Major Haemorrhage Transfusion Pathway SENIOR CLINICIAN ASSESSMENT: DECLARES MAJOR HAEMORRHAGE ( Call for help ( Telephone via switchboard: Consultant or Senior Clinician Duty Anaesthetist Porters (if will

More information

Active date July Ratification date: Review date January 2014 Applies to: Staff managing patients on warfarin. Exclusions:

Active date July Ratification date: Review date January 2014 Applies to: Staff managing patients on warfarin. Exclusions: Guideline Title: Guidelines for the management of warfarin reversal [key words : Beriplex, Octaplex, PCC, vitamin K, anticoagulant, anticoagulation] Authors: Dr Sarah Allford, Consultant Haematologist

More information

MASSIVE HAEMORRHAGE J DAVIES ROYAL DEVON AND EXETER NHS FOUNDATION TRUST. Respond Deliver & Enable

MASSIVE HAEMORRHAGE J DAVIES ROYAL DEVON AND EXETER NHS FOUNDATION TRUST. Respond Deliver & Enable MASSIVE HAEMORRHAGE J DAVIES ROYAL DEVON AND EXETER NHS FOUNDATION TRUST Definitions Loss of entire blood volume equivalent within 24hrs Loss of 50% of blood volume within 3hrs Continuing blood loss of

More information